MEMOLI, BRUNO
 Distribuzione geografica
Continente #
NA - Nord America 1.132
EU - Europa 498
AS - Asia 207
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.852
Nazione #
US - Stati Uniti d'America 1.098
CN - Cina 160
IT - Italia 147
IE - Irlanda 91
FI - Finlandia 78
UA - Ucraina 61
NL - Olanda 55
CA - Canada 33
DE - Germania 33
VN - Vietnam 28
CI - Costa d'Avorio 13
GB - Regno Unito 13
SE - Svezia 13
IN - India 5
BE - Belgio 4
HK - Hong Kong 4
FR - Francia 3
IR - Iran 3
TW - Taiwan 3
AU - Australia 1
EU - Europa 1
JP - Giappone 1
MX - Messico 1
MY - Malesia 1
SG - Singapore 1
TR - Turchia 1
Totale 1.852
Città #
Chandler 248
Princeton 82
Jacksonville 69
Millbury 64
Boston 59
Nanjing 57
Amsterdam 54
Napoli 42
Ashburn 41
Wilmington 37
Ann Arbor 33
Ottawa 30
Dong Ket 28
Beijing 25
Menlo Park 19
Nanchang 19
Des Moines 14
Houston 13
Jiaxing 13
Hebei 12
Shenyang 12
Woodbridge 11
Norwalk 9
Naples 7
Augusta 6
Dublin 6
Falls Church 6
Greifswald 6
Boardman 5
San Mateo 5
Washington 5
Changsha 4
Courcelles 4
Orange 4
Casoria 3
Hangzhou 3
Indiana 3
Kronberg 3
Kunming 3
Lanzhou 3
Redwood City 3
Rome 3
San Giorgio Ionico 3
Tianjin 3
Ardabil 2
Bologna 2
Chiaravalle 2
Monmouth Junction 2
Oliveto Citra 2
Pesaro 2
Seattle 2
Bacoli 1
Bari 1
Buxtehude 1
Changchun 1
Den Haag 1
Edinburgh 1
Greensboro 1
Guangzhou 1
Islington 1
Istanbul 1
Kaohsiung 1
L'aquila 1
Leawood 1
Milan 1
Modugno 1
Nola 1
Nürnberg 1
Ogden 1
Oleggio 1
Pinerolo 1
Pune 1
Ravenna 1
Riomaggiore 1
Round Lake 1
Salerno 1
Spilamberto 1
Spruce Grove 1
Sydney 1
Taipei 1
Taizhou 1
Tappahannock 1
Toluca 1
Torino 1
Toronto 1
Verona 1
Vimercate 1
Walnut 1
Wenatchee 1
Zhengzhou 1
Totale 1.132
Nome #
Effect of short-term synbiotic treatment on plasma p-cresol levels in patients with chronic renal failure: A randomized clinical trial 84
Plasma p-Cresol Lowering Effect of Sevelamer in Peritoneal Dialysis Patients: Evidence from a Cross-Sectional Observational Study. 53
CHANGES OF SERUM ALBUMIN AND C-REACTIVE PROTEIN ARE RELATED TO CHANGES OF INTERLEUKIN 6 RELEASE BY PERIPHERAL BLOOD MONONUCLEAR CELLS IN HEMODIALYSIS PATIENTS TREATED WITH DIFFERENT MEMBRANES. 51
Imaging of the peritoneum evaluated by 99mTc-icodextrin scintigraphy in peritoneal dialysis patients: preliminary data 51
Hemodialysis does not affect ventricular-arterial coupling beyond the reduction of blood pressure and preload. 46
Evidence That p-Cresol and IL-6 Are Adsorbed by the HFR Cartridge: Towards a New Strategy to Decrease Systemic Inflammation in Dialyzed Patients? 46
Nutritional-inflammation status and resistance to erythropoietin therapy in haemodialysis patients. 42
Body composition and cardiovascular risk factors in pretransplant hemodialysis patients 42
Downregulation of cell survival signalling pathways and increased cell damage in hydrogen peroxide-treated human renal proximal tubular cells by alpha-erythropoietin. 42
Body mass index and survival differences in dialysis patients 39
In vivo modulation of soluble "antagonistic" IL-6 receptor synthesis and release in ESRD 38
ROLE OF HFR CARTRIDGE IN THE REMOVAL OF MEDIATORS OF INFLAMMATION IN HEMODIALYSIS PATIENTS 38
Fetuin-A gene expression, synthesis and release in primary human hepatocytes cultured in a galactosylated membrane bioreactor. 37
Dietary phosphate restriction in dialysis patients: a new approach for the treatment of hyperphosphataemia. 37
EARLY IMPAIRMENT OF RENAL HEMODYNAMIC RESERVE IN PATIENTS WITH ASYMPTOMATIC HEART FAILURE IS RESTORED BY ANGIOTENSIN II ANTAGONISM. 35
Dietary Intake as a Link between Obesity, Systemic Inflammation, and the Assumption of Multiple Cardiovascular and Antidiabetic Drugs in Renal Transplant Recipients. 34
Hemodialysis does not affect ventricular-arterial coupling beyond the reduction of blood pressure and preload. 34
Efficacy of i.v. torasemide in the treatment of acute and chronic high grade renal failure 31
Abnormalities of bioimpedance measures in overweight and obese hemodialyzed patients. 30
INTERLEUKIN 2-INDUCED RENAL DYSFUNCTION IN CANCER PATIENTS IS REVERSED BY LOW-DOSE DOPAMINE INFUSION 29
ROLE OF DIFFERENT DIALYSIS MEMBRANES IN THE RELEASE OF INTERLEUKIN 6 SOLUBLE RECEPTOR IN UREMIC PATIENTS. 29
Effect of maintenance treatment with mycophenolate mofetil on chronic inflammatory status in proliferative lupus nephritis. 29
Effects of uremia, acetate and bicarbonate dialysis on beta-adrenergic responsiveness as assessed by epinephrine-stimulated adenylate cyclase 29
Nutritional intervention in a hemodialysis pregnant woman: a case report 28
A translational approach to micro-inflammation in End Stage Renal Disease: molecular effects of low levels of Interleukin 6. 28
Immunomodulatory Effect of Continuous Venovenous Hemofiltration during Sepsis: Preliminary Data 28
HEMODIALYSIS-RELATED LYMPHOMONONUCLEAR RELEASE OF INTERLEUKIN 12 IN PATIENTS WITH END-STAGE RENAL DISEASE. 27
Myocardial fibrosis and diastolic dysfunction in patients on chronic haemodialysis 27
Loculated fluid collections evidenced by peritoneal scintigraphy. 26
Effects of a diet rich in N-3 polyunsaturated Fatty acids on systemic inflammation in renal transplant recipients. 26
Interleukin-6 release from peripheral mononuclear cells is associated to disease activity and treatment response in patients with lupus nephritis. 25
Acute renal and immunological effects of low-dose cyclosporin in humans. 25
Beneficial effects of better control of secondary hyperparathyroidism with paricalcitol in chronic dialysis patients. 25
Effect of maintenance treatment with mycophenolate mofetil on chronic inflammatory status in proliferative lupus nephritis 25
Comparison of vector and conventional bioelectrical impedance analysis in the optimal dry weight prescription in hemodialysis. 24
Hemodialysis related interleukin-2 receptor release by peripheral blood mononuclear cells. 24
Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. 24
HEMODIALYSIS-RELATED INDUCTION OF INTERLEUKIN 6 PRODUCTION BY PERIPHERAL BLOOD MONONUCLEAR CELLS 23
Acute increase in plasma osmolality as a cause of hyperkalemia in patients with renal failure. 23
Bicarbonate and calcium kinetics in postdilutional hemodiafiltration. 23
Cytokine production in standard hemodialysis with a new polyethersulfone membrane: a cross-over study. 23
EFFECT OF MAINTENANCE TREATMENT WITH MYCOPHENOLATE MOFETIL ON CHRONIC INFLAMMATORY STATUS IN PROLIFERATIVE LUPUS NEPHRITIS 23
RENAL FUNCTIONAL RESERVE. ITS SIGNIFICANCE IN NORMAL AND SALT DEPLETION CONDITION. 22
: Low dose dopamine induces early recovery of recombinant Interleukin-2 impaired renal function. 22
Cytokine production in haemodialysis. 22
Effect of dialysate sodium concentration on interdialytic increase of potassium. 22
Human plasma ultrafiltrate purification by membrane distillation: process optimisation and evaluation of its possible application on-line 22
Stop Flow in abdominal and pelvic cancer relapses. 21
Inflammation may modulate IL-6 and C-reactive protein gene expression in the adipose tissue: the role of IL-6 cell membrane receptor 20
INFLAMMATORY EFFECTS OF PERITONEAL DIALYSIS. EVIDENCE OF SYSTEMIC MONOCYTE ACTIVATION. 19
È L’ERITROPOIETINA SEMPRE CITOPROTETTIVA NEI CONFRONTI DELLO STRESS OSSIDATIVO? 18
Local activation of interleukin 6 signaling is associated with arteriovenous fistula stenosis in hemodialysis patients. 17
Extra-natriuretic effects of atrial peptide in humans. 17
Pleural effusion in peritoneal dialysis: overload or leakage? 17
Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD. 16
Loop diuretics and renal vasodilators in acute renal failure. 14
[The IL-6 soluble receptors in hemodialyzed patients]. 13
Hepatocellular functions of human liver cells in oxygen-permeable membrane device 13
Long-term maintenance of human hepatocytes in oxygen-permeable membrane bioreactor. 12
Membrane distillation of human plasma ultrafiltrate and its theoretical applications to haemodialysis techniques. 12
Evidence on the prevalence and geographic distribution of major cardiovascular risk factors in Italy. 12
Il litio come marker del riassorbimento tubulare prossimale 12
Mycophenolic acid inhibits the phosphorylation of NF-kappaB and JNKs and causes a decrease in IL-8 release in H2O2-treated human renal proximal tubular cells. 11
The place of loop diuretics in the treatment of acute and chronic renal failure. 11
Human mature adipocytes express albumin and this expression is not regulated by inflammation. 11
Interleukin-6 production induced in peripheral blood mononuclear cells by a serum factor from IgA nephropathy patients is inhibited in vitro by specific sugars. 10
Effects of uremia, acetate and bicarbonate dialysis on beta-adrenergic responsiveness as assessed by epinephrine-stimulated adenylate cyclase. 10
Role of inhibition of atrial natriuretic factor release in the down-regulation of salt excretion. 10
"Obesity paradox" or a better nutritional status? 10
Radiocontrast media cause dephosphorylation of Akt and downstream signaling targets in human renal proximal tubular cells. 10
Serum fetuin a in hemodialysis: a link between derangement of calcium-phosphurus homeostasis and progression of atherosclerosis? 9
Twice versus thrice weekly administration of intravenous calcitriol in dialysis patients: a randomized prospective trial. Gruppo Italiano di Studio dell'Osteodistrofia Renale. 9
[Guidelines for dialysis. Replacement therapy for acute renal failure in critically ill patients]. 9
On the pathophysiology of functional acute renal failure. 9
Renal hemodynamic response to maximal vasodilating stimulus in healthy older subjects. 9
Stop-flow technique for loco-regional delivery of high dose chemotherapy in the treatment of advanced pelvic cancers. 9
Human galactosylated membrane bioreactor for the long-term maintenance of liver specific functions 9
Intrarenal determinants of sodium retention in mild heart failure: effects of angiotensin-converting enzyme inhibition. 8
Proteomic analysis of peritoneal fluid of patients treated by peritoneal dialysis: effect of glucose concentration. 8
Human hepatocyte functions in a galactosylated membrane bioreactor. 8
Interleukin-6 production of uraemic haemodialysed patients: effects of different membranes. 7
The role of interleukin-6 and of its soluble receptors in the biocompatibility of dialysis treatment. 7
Totale 1.930
Categoria #
all - tutte 8.349
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.349


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20197 0 0 0 0 0 0 0 0 0 1 1 5
2019/2020265 100 10 13 0 19 30 8 4 6 6 37 32
2020/2021206 7 13 15 15 17 24 17 3 18 4 43 30
2021/2022428 7 1 0 0 0 6 5 23 80 47 96 163
2022/2023541 86 53 8 46 62 64 0 54 92 56 15 5
2023/2024161 7 45 23 23 14 18 9 22 0 0 0 0
Totale 1.930